体感诱发电位N20波幅随时间变化能否预测心脏骤停后昏迷幸存者的结局
该研究为ProNeCA多中心预后研究数据集的回顾性分析(NCT03849911),纳入236例在ROSC后12-24小时和72小时均记录体感诱发电位(SSEP)的成人心脏骤停后昏迷幸存者,评估N20波幅(N20Amp)在这两个时间点的变化及其对6个月不良神经结局(CPC 3-5)的预测价值。结果显示,N20Amp中位数从12-24小时的1.90 µV升至72小时的2.86 µV(p=0.0019);0%假阳性率对应的N20Amp截止值从12-24小时的0.6 µV升至72小时的1.23 µV,敏感度从56%升至71%。12-24小时至72小时N20Amp下降>53%预测不良结局的假阳性率为0%,敏感度为26%;与72小时N20Amp<1.23 µV联合可将敏感度提高1%至72%。结论提示,N20Amp及其预测不良结局的截止值在ROSC后12-24小时至72小时之间升高,N20Amp下降>53%或72小时低波幅均提示不良预后。
要点
- 236例成人心脏骤停后昏迷幸存者中,N20Amp中位数从ROSC后12-24小时的1.90 µV升至72小时的2.86 µV(p=0.0019)。
- 0%假阳性率下,N20Amp预测6个月不良神经结局(CPC 3-5)的截止值从12-24小时的0.6 µV升至72小时的1.23 µV,敏感度从56%升至71%。
- 12-24小时至72小时N20Amp下降>53%预测不良结局的假阳性率为0%,敏感度为26%。
- N20Amp下降>53%与72小时N20Amp<1.23 µV联合,敏感度提高1%至72%。
- 72小时低N20Amp(<1.23 µV)或较12-24小时下降>53%均为不良预后信号,且假阳性率为0%。
适用人群与场景
- 成人心脏骤停后昏迷幸存者,且在ROSC后12-24小时和72小时两个时间点均记录了SSEP。
诊断标准与关键阈值
- 不良神经结局定义为6个月时CPC 3-5。
- 12-24小时N20Amp截止值0.6 µV(0%假阳性率),敏感度56[48-64]%。
- 72小时N20Amp截止值1.23 µV(0%假阳性率),敏感度71[63-77]%。
- 12-24小时至72小时N20Amp下降>53%(0%假阳性率),敏感度26[19-35]%。
研究设计与关键结果
- 研究类型:ProNeCA多中心预后研究数据集(NCT03849911)的回顾性分析;样本量236例。
- N20Amp中位数[IQR]从12-24小时的1.90[0.78-4.22] µV升至72小时的2.86[1.52-5.10] µV(p=0.0019)。
- 0%假阳性率下N20Amp截止值从12-24小时的0.6 µV升至72小时的1.23 µV,敏感度从56[48-64]%升至71[63-77]%。
- 12-24小时至72小时N20Amp下降>53%预测不良结局:假阳性率0[0-5]%,敏感度26[19-35]%。
- N20Amp下降>53%联合72小时N20Amp<1.23 µV:敏感度提高1%至72[64-79]%。
证据类型、等级与局限
- 证据类型:多中心预后研究数据集的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在ROSC后12-24小时和72小时分别记录SSEP N20Amp,有助于识别不良神经结局(CPC 3-5)。
- 72小时N20Amp<1.23 µV或较12-24小时下降>53%提示不良预后,假阳性率为0%。
- N20Amp下降>53%单独应用的敏感度较低(26%),与72小时N20Amp<1.23 µV联合可将敏感度提高至72%。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To assess if the amplitude of the N20 wave (N20Amp) of somatosensory evoked potentials (SSEPs) changes between 12-24 h and 72 h from the return of spontaneous circulation (ROSC) after cardiac arrest and if an N20Amp decrease predicts poor neurological outcome (CPC 3-5) at six months.
SETTING: Retrospective analysis of the ProNeCA multicentre prognostication study dataset. (NCT03849911).
METHODS: In adult comatose cardiac arrest survivors whose SSEPs were recorded at both 12-24 h and 72 h after ROSC, we measured the median N20Amp at each timepoint and the individual change in N20Amp across the two timepoints. We identified their cutoffs for predicting poor outcome with 0% false positive rate (FPR) and compared their sensitivities.
RESULTS: We included 236 patients. The median [IQR] N20Amp increased from 1.90 [0.78-4.22] µV to 2.86 [1.52-5.10] µV between 12-24 h and 72 h (p = 0.0019). The N20Amp cutoff for 0% FPR increased from 0.6 µV at 12-24 h to 1.23 µV at 72 h, and its sensitivity increased from 56[48-64]% to 71[63-77]%. Between 12-24 h and 72 h, an N20Amp decrease > 53% predicted poor outcome with 0[0-5]% FPR and 26[19-35]% sensitivity. Its combination with an N20Amp < 1.23 µV at 72 h increased sensitivity by 1% to 72[64-79]%.
CONCLUSION: In comatose cardiac arrest survivors, the median N20Amp and its cutoff for predicting poor neurological outcome increase between 12-24 and 72 h after ROSC. An N20Amp decrease greater than 53% between these two timepoints predicts poor outcome with 0% FPR, confirming the unfavourable prognostic signal of a low N20Amp at 72 h.
参考来源
- Scarpino M, Lolli F, Lanzo G, et al. Do changes in SSEP amplitude over time predict the outcome of comatose survivors of cardiac arrest? Resuscitation. 2022. PMID: 36375653. doi:10.1016/j.resuscitation.2022.10.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。